DR. NOAH BERKOWITZ, M.D., PH.D.
Osteopathic Medicine at Disbrow Cir, New Rochelle, NY
License number
New York 198477-1
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
20 Disbrow Cir, New Rochelle, NY 10804
Phone
(201) 906-1953
Organization information
See more information about NOAH BERKOWITZ at bizstanding.comNoah Berkowitz MD,PHD
20 Disbrow Cir, New Rochelle, NY 10804
Industry:
Internist
Phone:
(201) 906-1953 (Phone)
Noah Berkowitz
Professional information
Dr. Noah C Berkowitz, New Rochelle NY - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
20 Disbrow Cir, New Rochelle 10804
(201) 906-1953 (Phone)
(201) 906-1953 (Phone)
Certifications:
Internal Medicine, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1994
New York-Presbyterian Hospital
Nat Cancer Inst
Columbia University / College of Physicians And Surgeons
Graduated: 1994
New York-Presbyterian Hospital
Nat Cancer Inst
Reduction In Myocardial Infarction Size
US Patent:
2007001, Jan 18, 2007
Filed:
Jul 18, 2005
Appl. No.:
11/183251
Inventors:
Andrew Levy - Kiryat Shmuel, IL
Noah Berkowitz - New Rochelle NY, US
Noah Berkowitz - New Rochelle NY, US
International Classification:
A61K 38/20, A61K 38/44, A61K 38/17
US Classification:
424085200, 514012000, 424094400
Abstract:
This invention provides methods and compositions used for reducing the Myocaidial Infarct (MI) size in diabetic subjects exhibiting the haptoglobin (Hp) 2 allele. Specifically, the invention relates to reduction of MI in diabetic subjects carrying the Hp-2 allele by reducing the oxidative sterss in these subjects following ischemia-reperfusion injury.
Use Of Haptoglobin Genotyping In Diagnosis And Treatment Of Intraplaque Hemorrhage Resulting From Plaque Rupture
US Patent:
2009005, Feb 26, 2009
Filed:
Jun 5, 2008
Appl. No.:
12/155561
Inventors:
Andrew Levy - Haifa, IL
Noah Berkowitz - New Rochelle NY, US
Noah Berkowitz - New Rochelle NY, US
International Classification:
A61K 31/395, C12Q 1/68, A61P 9/00
US Classification:
514183, 435 6
Abstract:
This invention relates to methods for providing prognosis of a subjects susceptibility to plaque rupture and compositions for treating plaque rupture and intraplaque hemorrhage. Specifically, the invention is directed to the use of haptoglobin genotyping in determining the susceptibility of a subject to develop intraplaque hemorrhage resulting from plaque rapture and treatment of the intraplaque hemorrhage using antioxidants.
Use Of Haptoglobin Genotyping In Diagnosis And Treatment Of Defective Reverse Cholesterol Transport (Rct)
US Patent:
2009007, Mar 19, 2009
Filed:
May 14, 2008
Appl. No.:
12/153186
Inventors:
Noah Berkowitz - New Rochelle NY, US
Andrew Levy - Haifa, IL
Andrew Levy - Haifa, IL
International Classification:
A61K 38/44, C12Q 1/68, A61K 31/355, A61K 31/35
US Classification:
424 944, 435 6, 514458, 514460
Abstract:
A method of determining a potential of a nondiabetic or diabetic patient to benefit from reverse cholesterol transport therapy for treatment of a vascular complication, followed by methods and compositions of treating the diagnosed vascular complications comprising determining a haptoglobin phenotype of the patient. Reverse cholesterol transport therapy includes inhibition of cholesteryl ester transport protein, such as by using the compound torcetrapib.
Reagents And Methods For Detecting A Polymorphic Protein
US Patent:
2011029, Dec 1, 2011
Filed:
Jun 11, 2009
Appl. No.:
12/997856
Inventors:
Jacob Victor - Passaic NJ, US
Noah Berkowitz - New Rochelle NY, US
Andrew Levy - Haifa, IL
Noah Berkowitz - New Rochelle NY, US
Andrew Levy - Haifa, IL
International Classification:
G01N 33/566, C12N 5/10, C07K 16/18, G01N 33/577, C07H 21/00, C12N 9/96, C12N 7/01
US Classification:
435 792, 435188, 435326, 4352351, 436501, 536 2353, 53038825, 5303873
Abstract:
The present invention provides antibodies that differentially react with allelic variants of a polymorphic protein, methods of identifying same, an antigen binding fragment comprised therein, proteins, cells, viral particles, compositions, and kits comprising same. The invention also provides methods for determining a haptoglobin type of a subject and methods for testing a subject for susceptibility to diabetic complications.
Glutathione Peroxidase Mimetics And Uses Thereof
US Patent:
7923442, Apr 12, 2011
Filed:
Oct 6, 2006
Appl. No.:
11/543994
Inventors:
Dusan Kuzma - Calgary, CA
Thomas G. Back - Calgary, CA
Noah Berkowitz - New Rochelle NY, US
Thomas G. Back - Calgary, CA
Noah Berkowitz - New Rochelle NY, US
Assignee:
UTI Limited Partnership - Calgary
International Classification:
A61K 31/33, C07D 293/00, C07D 329/00
US Classification:
514183, 540 1
Abstract:
This invention relates to novel organoselenium and tellurium compounds, processes of producing the same and methods of use thereof. The compounds function as mimetics for the catalyst selenoenzyme glutathione peroxidase, which protects cells from oxidative stress.
Haptoglobin Genotyping For Prognosis And Treatment Of Chronic Vasospasm Following Subarachnoid Hemorrhage (Sah)
US Patent:
2009001, Jan 15, 2009
Filed:
Jun 5, 2008
Appl. No.:
12/155560
Inventors:
Andrew Levy - Haifa, IL
Noah Berkowitz - New Rochelle NY, US
Noah Berkowitz - New Rochelle NY, US
International Classification:
A61K 31/555, G01N 33/53, A61P 9/14, C12M 1/34
US Classification:
514186, 435 71, 435 792, 4352872, 514184
Abstract:
This invention relates to methods and systems for providing a prognosis to a subject on developing vasospasm as a results of hemorrhagic event, and compounds and compositions for treatment thereof. Specifically, the invention relates to the use of haptoglobin genotyping in the prognosis of the development of vasospasm following SAH, and antioxidants such as glutathione peroxidase mimetics for treatment.
Glutathione Peroxidase Mimetics For Treatment Of Neurodegenerative, Pulmonary And Inflammatory Diseases
US Patent:
2008023, Sep 25, 2008
Filed:
Feb 19, 2008
Appl. No.:
12/071271
Inventors:
Noah Berkowitz - New Rochelle NY, US
International Classification:
A61K 31/33, A61K 31/395, A61K 31/335, A61K 31/4523, A61K 31/496, A61P 11/00, A61P 29/00, A61P 19/02, A61P 35/00, A61P 25/00, A61P 25/28
US Classification:
51425213, 514183, 514473, 514462, 514326
Abstract:
This invention relates to compositions and methods for the treatment of neurodegenerative, pulmonary and inflammatory diseases described herein with glutathione peroxidase and its mimetics.
Glutathione Peroxidase Mimetics For The Treatment Of Dermatoses
US Patent:
2008020, Aug 28, 2008
Filed:
Feb 19, 2008
Appl. No.:
12/071272
Inventors:
Noah Berkowitz - New Rochelle NY, US
International Classification:
A61K 31/4353, A61P 17/02
US Classification:
514300
Abstract:
This invention relates to compositions and methods for the treatment of dermatological conditions with a glutathione peroxidase mimetic.